- Paediatrics (RCH) - Research Publications
Paediatrics (RCH) - Research Publications
Permanent URI for this collection
3 results
Filters
Reset filtersSettings
Statistics
Citations
Search Results
Now showing
1 - 3 of 3
-
ItemPartially Methylated Alleles, Microdeletion, and Tissue Mosaicism in a Fragile X Male with Tremor and Ataxia at 30 Years of Age: A Case ReportHwang, YT ; Mabel Aliaga, S ; Arpone, M ; Francis, D ; Li, X ; Chong, B ; Slater, HR ; Rogers, C ; Bretherton, L ; Hunter, M ; Heard, R ; Godler, DE (WILEY-BLACKWELL, 2016-12)
-
ItemMolecular Inconsistencies in a Fragile X Male with Early Onset AtaxiaHwang, YT ; Dudding, T ; Mabel Aliaga, S ; Arpone, M ; Francis, D ; Li, X ; Slater, HR ; Rogers, C ; Bretherton, L ; du Sart, D ; Heard, R ; Eugeny Godler, D (MDPI AG, 2016-09)Mosaicism for FMR1 premutation (PM: 55-199 CGG)/full mutation (FM: >200 CGG) alleles or the presence of unmethylated FM (UFM) have been associated with a less severe fragile X syndrome (FXS) phenotype and fragile X associated tremor/ataxia syndrome (FXTAS)-a late onset neurodegenerative disorder. We describe a 38 year old male carrying a 100% methylated FM detected with Southern blot (SB), which is consistent with complete silencing of FMR1 and a diagnosis of fragile X syndrome. However, his formal cognitive scores were not at the most severe end of the FXS phenotype and he displayed tremor and ataxic gait. With the association of UFM with FXTAS, we speculated that his ataxia might be related to an undetected proportion of UFM alleles. Such UFM alleles were confirmed by more sensitive PCR based methylation testing showing FM methylation between 60% and 70% in blood, buccal, and saliva samples and real-time PCR analysis showing incomplete silencing of FMR1. While he did not meet diagnostic criteria for FXTAS based on MRI findings, the underlying cause of his ataxia may be related to UFM alleles not detected by SB, and follow-up clinical and molecular assessment are justified if his symptoms worsen.
-
ItemSignificantly Elevated FMR1 mRNA and Mosaicism for Methylated Premutation and Full Mutation Alleles in Two Brothers with Autism Features Referred for Fragile X TestingField, M ; Dudding-Byth, T ; Arpone, M ; Baker, EK ; Aliaga, SM ; Rogers, C ; Hickerton, C ; Francis, D ; Phelan, DG ; Palmer, EE ; Amor, DJ ; Slater, H ; Bretherton, L ; Ling, L ; Godler, DE (MDPI, 2019-08-02)Although fragile X syndrome (FXS) is caused by a hypermethylated full mutation (FM) expansion with ≥200 cytosine-guanine-guanine (CGG) repeats, and a decrease in FMR1 mRNA and its protein (FMRP), incomplete silencing has been associated with more severe autism features in FXS males. This study reports on brothers (B1 and B2), aged 5 and 2 years, with autistic features and language delay, but a higher non-verbal IQ in comparison to typical FXS. CGG sizing using AmplideX PCR only identified premutation (PM: 55-199 CGGs) alleles in blood. Similarly, follow-up in B1 only revealed PM alleles in saliva and skin fibroblasts; whereas, an FM expansion was detected in both saliva and buccal DNA of B2. While Southern blot analysis of blood detected an unmethylated FM, methylation analysis with a more sensitive methodology showed that B1 had partially methylated PM alleles in blood and fibroblasts, which were completely unmethylated in buccal and saliva cells. In contrast, B2 was partially methylated in all tested tissues. Moreover, both brothers had FMR1 mRNA ~5 fold higher values than those of controls, FXS and PM cohorts. In conclusion, the presence of unmethylated FM and/or PM in both brothers may lead to an overexpression of toxic expanded mRNA in some cells, which may contribute to neurodevelopmental problems, including elevated autism features.